Rotigaptide (ZP123) reverts established atrial conduction velocity slowing

Cell Communication and Adhesion

Volumn 12, Issue 5-6, 2005, Pages 271-278

  Haugan, Ketil ^a   Kjølbye, Anne Louise ^a   Hennan, James K ^b   Petersen, Jørgen Søberg ^a  

^a Zealand Pharma AS   (Denmark)

^b PFIZER INC   (United States)

Author keywords

Antiarrhythmic agents; Atrial; Conduction velocity; Gap junctions

Indexed keywords

ANTIARRHYTHMIC PEPTIDE; ROTIGAPTIDE; UNCLASSIFIED DRUG; ZP 123;

ACTION POTENTIAL; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GAP JUNCTION; HEART ATRIUM CONDUCTION; HEART ATRIUM CONTRACTILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; HEART ATRIA; HEART CONDUCTION SYSTEM; MALE; MYOCARDIAL CONTRACTION; OLIGOPEPTIDES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 33645007430     PISSN: 10615385     EISSN: 15435180     Source Type: Journal    
DOI: 10.1080/15419060500514135     Document Type: Article

References (16)

1. Aonuma, S and Kohama, Y and Akai, K and Komiyama, Y and Nakajima, S and Wakabayashi, M and Makino, T. (1980) Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters Chem Pharm Bull (Tokyo), 28, pp. 3332 - 3339. [CSA]
2. Xing, D and Kjølbye, A and Nielsen, M and Petersen, J and Harlow, K and Holstein-Rathlou, N and Martins, J. (2003) ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs J Cardiovasc Electrophysiol, 14, pp. 510 - 520. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
3. Eloff, B and Gilat, E and Wan, X and Rosenbaum, D. (2003) Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: Evidence supporting a novel target for antiarrhythmic therapy Circulation, 108, pp. 3157 - 3163. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
4. Haugan, K and Olsen, K and Hartvig, L and Petersen, J and Holstein-Rathlou, N and Hennan, J and Nielsen, M. (2005) The antiarrhythmic peptide analogue ZP123 prevents atrial conduction slowing during metabolic stress J Cardiovasc Electrophysiol, 16, pp. 537 - 545. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
5. Hennan, J and Swillo, R and Morgan, G and Keith, J and Schaub, R and Smith, R and Feldman, H and Haugan, K and Kantrowitz, J and Wang, P and Abu-Qare, A and Butera, J and Larsen, B and Crandall, D. (2005) Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs J Pharmacol Exp Ther: Epub. DOI: 10.1124/jpet.105.096933 [CSA]
6. Muller, A and Gottwald, M and Tudyka, T and Linke, W and Klaus, W and Dhein, S. (1997) Increase in gap junction conductance by an antiarrhythmic peptide Eur J Pharmacol, 327, pp. 65 - 72. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
7. Kjølbye, A and Knudsen, C and Jepsen, T and Larsen, B and Petersen, J. (2003) Pharmacological Characterization of the New Stable Antiarrhythmic Peptide Analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): In Vivo and in Vitro Studies J Pharmacol Exp Ther, 306, pp. 1191 - 1199. [CSA] [CROSSREF]
8. Rohr, S and Kucera, J and Kleber, A. (1998) Slow conduction in cardiac tissue, I: Effects of a reduction of excitability versus a reduction of electrical coupling on microconduction Circ Res, 83, pp. 781 - 794. [PUBMED] [INFOTRIEVE] [CSA]
9. Xing, D and Kjølbye, A and Petersen, J and Martins, J. (2005) Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs Am J Physiol Heart Circ Physiol, 288, pp. H511 - H516. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
10. Lampe, P and Lau, A. (2004) The effects of connexin phosphorylation on gap junctional communication Int J Biochem Cell Biol, 36, pp. 1171 - 1186. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
11. Weng, S and Lauven, M and Schaefer, T and Polontchouk, L and Grover, R and Dhein, S. (2002) Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation FASEB J., 16, pp. 1114 - 1116. [PUBMED] [INFOTRIEVE] [CSA]
12. Dhein, S and Larsen, B and Petersen, J and Mohr, F. (2003) Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern Cell Commun Adhes, 10, pp. 371 - 378. [PUBMED] [INFOTRIEVE] [CSA]
13. Axelsen, L and Mohammed, S and Kjølbye, A and Nielsen, M and Holstein-Rathlou, N and Jensen, O and Andersen, S and Hennan, J and Stahlhut, M. (2005) Serine 297 and Serine 306: Two new phosphorylation sites involved in the regulation of connexin43 during ischemia Circulation, 112(17), pp. II-114. Abstract No. 635 [CSA]
14. Schaffer, P and Ahammer, H and Muller, W and Koidl, B and Windisch, H. (1994) Di-4-ANEPPS causes photodynamic damage to isolated cardiomyocytes Pflugers Arch., 426, pp. 548 - 551. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
15. Qin, H and Kay, M and Chattipakorn, N and Redden, D and Ideker, R and Rogers, J. (2003) Effects of heart isolation, voltage-sensitive dye, and electromechanical uncoupling agents on ventricular fibrillation Am J Physiol Heart Circ Physiol, 284, pp. H1818 - H1826. [PUBMED] [INFOTRIEVE] [CSA]
16. Liu, Y and Cabo, C and Salomonsz, R and Delmar, M and Davidenko, J and Jalife, J. (1993) Effects of diacetyl monoxime on the electrical properties of sheep and guinea pig ventricular muscle Cardiovasc Res, 27, pp. 1991 - 1997. [PUBMED] [INFOTRIEVE] [CSA]